Insulet Adds Abbott's FreeStyle Libre 2 Plus to Omnipod 5's Compatibility Roster

Yahoo FinanceNov 21 21:27

CCORF Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $269

Futu NewsNov 21 20:34 · Ratings

Insulet's Strategic Advancements and Market Positioning Drive Buy Rating

TipRanksNov 21 19:55 · Ratings

Citi Research's 'SMID Value' Rec List – CHWY, FHN, PODD, and More

Seeking AlphaNov 21 02:59

Insulet To Present At Wolfe Research Healthcare Conference; Webcast At 12:00 PM ET

RTTNewsNov 21 00:04

Insulet Announces Omnipod 5 System Is Now Compatible With Abbott's FreeStyle Libre 2 Plus Sensor In The U.S.

BenzingaNov 20 21:38